Join
Live feed
·
INSIDERFilingvia Quantisnow
Talaris Therapeutics Inc. logo

Srivastava Sapna was granted 518 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TALS· Talaris Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TALS (Talaris Therapeutics Inc.) and more on Quantisnow.